Home » Glaxo Avoids Market for Lemons by Buying Collaborators
Glaxo Avoids Market for Lemons by Buying Collaborators
GlaxoSmithKline may find its next acquisition target where the UK drugmaker found the last two: among more than a dozen companies it collaborates with to develop new treatments.
Bloomberg
Bloomberg
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May